Wednesday
August 13, 2025
8:30 AM ET
IceCure Reports Financial & Operational Results for the First Half of 2025
Tuesday
July 29, 2025
9:00 AM ET
IceCure Announces Expiration and Results of Approximately Two Times Over-Subscribed Rights Offering for Aggregate Gross Proceeds of $10.0 Million
Thursday
July 3, 2025
8:30 AM ET
IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025
Wednesday
May 28, 2025
8:30 AM ET
IceCure Medical Reports First Quarter 2025 Financial Results
Wednesday
May 21, 2025
8:30 AM ET
IceCure to Report First Quarter 2025 Financial & Operational Results on May 28, 2025
Thursday
March 27, 2025
8:30 AM ET
IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America
Monday
March 24, 2025
8:30 AM ET
IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate